Company / Cash per Share
Inmune Bio, Inc. Cash per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.17
FY2024
5-year range
$1.17 / $5.55
FY2020-FY2024
Trend
-41.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has declined for 3 consecutive years, from $5.55 in FY2021 to $1.17 in FY2024.
Based on SEC 10-K filings.
1.17 in FY2024 with a 3-year CAGR of -40.6%.
Declined from $2.92 to $1.17 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -40.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Inmune Bio, Inc.'s cash per share has declined for 3 consecutive years.
- In FY2024, cash per share decreased 41.7% year-over-year.
- Peak cash per share was recorded in FY2021.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 49.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $1.17 | -41.7% |
| FY2023 | $2.00 | -31.7% |
| FY2022 | $2.92 | -47.3% |
| FY2021 | $5.55 | +754.4% |
| FY2020 | $0.65 | +294.2% |
| FY2018 | $0.16 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026